Ad is loading...
MENU
BDTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Black Diamond Therapeutics (BDTX) Ownership - Who owns Black Diamond Therapeutics?
Profile
Industry
N/A
Address
One Main Street
Phone
+1 617 252-0848
Employees
54
Web
https://www.blackdiamondtherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
137.5M
P/E Ratio
N/A
Total Cash
112.68M
Projected Growth
N/A
Total Debt
23M
Revenue
N/A
Risk (Beta)
3.53
Dividend Yield
N/A
Total Cash/Share
1.99
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BDTX
Capitalization
138M
P/E Ratio
N/A
Risk (Beta)
3.53
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
1.99
Total Debt
23M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
97.4M
P/B Ratio
1.48
Cash Flow
N/A
Earnings
-1.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
5.55
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-81.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-47.12
Shares Held By Institutions
301M
Shares Outstanding - Current
56.6M
Total Liabilities
40.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-13.523
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 252-0848
Employees
54
Web
https://www.blackdiamondtherapeutics.com